IBL HealthCare Limited (PSX:IBLHL)
Pakistan · Delayed Price · Currency is PKR 46.02
-0.23 (-0.50%)
At close: May 13, 2026
IBL HealthCare Income Statement
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 4,483 | 4,322 | 3,603 | 4,028 | 3,651 | 3,004 | |
Revenue Growth (YoY) | 25.70% | 19.96% | -10.54% | 10.32% | 21.55% | 12.73% |
Cost of Revenue | 2,782 | 2,879 | 2,654 | 2,691 | 2,400 | 1,985 |
Gross Profit | 1,701 | 1,444 | 949.32 | 1,336 | 1,251 | 1,019 |
Selling, General & Admin | 1,203 | 999.3 | 795.96 | 726.7 | 680.77 | 606.06 |
Other Operating Expenses | -24.84 | - | - | - | - | - |
Operating Expenses | 1,179 | 999.3 | 795.96 | 726.7 | 680.77 | 612.19 |
Operating Income | 521.98 | 444.59 | 153.35 | 609.68 | 570.69 | 406.77 |
Interest Expense | -42.2 | -58.29 | -65.43 | -64.14 | -25.7 | -26.34 |
Interest & Investment Income | - | - | - | - | - | 10.47 |
Currency Exchange Gain (Loss) | -12.51 | -12.51 | 27.18 | -109.57 | -72.83 | 3.87 |
Other Non Operating Income (Expenses) | 13.29 | 3.3 | 3.7 | 22.86 | 9.81 | 13.09 |
EBT Excluding Unusual Items | 480.56 | 377.09 | 118.8 | 458.82 | 481.97 | 407.87 |
Gain (Loss) on Sale of Assets | - | - | - | 0.01 | 1.92 | - |
Asset Writedown | - | - | -10.1 | - | -0.62 | - |
Pretax Income | 480.56 | 377.09 | 108.7 | 458.83 | 483.27 | 409.15 |
Income Tax Expense | 240.17 | 168.72 | 101.15 | 149.87 | 180.41 | 108.66 |
Net Income | 240.39 | 208.37 | 7.56 | 308.96 | 302.86 | 300.49 |
Net Income to Common | 240.39 | 208.37 | 7.56 | 308.96 | 302.86 | 300.49 |
Net Income Growth | - | 2658.05% | -97.56% | 2.02% | 0.79% | 36.57% |
Shares Outstanding (Basic) | 98 | 99 | 99 | 99 | 99 | 99 |
Shares Outstanding (Diluted) | 98 | 99 | 99 | 99 | 99 | 99 |
Shares Change (YoY) | -0.36% | - | - | - | 0.00% | -0.00% |
EPS (Basic) | 2.45 | 2.11 | 0.08 | 3.14 | 3.07 | 3.05 |
EPS (Diluted) | 2.45 | 2.11 | 0.08 | 3.14 | 3.07 | 3.05 |
EPS Growth | - | 2658.06% | -97.56% | 2.02% | 0.79% | 36.57% |
Free Cash Flow | 19.51 | -278.81 | 566.44 | 24.34 | 55.56 | 65.09 |
Free Cash Flow Per Share | 0.20 | -2.83 | 5.75 | 0.25 | 0.56 | 0.66 |
Dividend Per Share | - | - | - | - | 0.659 | 0.549 |
Dividend Growth | - | - | - | - | 19.98% | -49.99% |
Gross Margin | 37.94% | 33.40% | 26.35% | 33.18% | 34.28% | 33.92% |
Operating Margin | 11.64% | 10.29% | 4.26% | 15.14% | 15.63% | 13.54% |
Profit Margin | 5.36% | 4.82% | 0.21% | 7.67% | 8.29% | 10.00% |
Free Cash Flow Margin | 0.43% | -6.45% | 15.72% | 0.60% | 1.52% | 2.17% |
EBITDA | 527.32 | 447.81 | 156.44 | 612.95 | 575.98 | 411.77 |
EBITDA Margin | 11.76% | 10.36% | 4.34% | 15.22% | 15.78% | 13.71% |
D&A For EBITDA | 5.34 | 3.22 | 3.09 | 3.28 | 5.29 | 5 |
EBIT | 521.98 | 444.59 | 153.35 | 609.68 | 570.69 | 406.77 |
EBIT Margin | 11.64% | 10.29% | 4.26% | 15.14% | 15.63% | 13.54% |
Effective Tax Rate | 49.98% | 44.74% | 93.05% | 32.66% | 37.33% | 26.56% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.